Bexson Biomedical
Ketamine and wearable device for post-operative pain.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD30—45m (Dealroom.co estimates Feb 2021.)
Santa Barbara California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$4.8m | Series A | ||
Total Funding | AUD7.4m |